Picture Demy-Colton BioFuture 2021 NYC C Virtual Option 650x80px
Organisation › Details

Alkermes (Group)

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases and oncology. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for diseases that include schizophrenia, depression, addiction, multiple sclerosis, and cancer. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. *


Period Start 1997-06-28 existent
Product Industry pharmaceutical
Region Region Cambridge, MA
  Country United States (USA)
  Street 1 Burlington Road
Connaught House
  City D04 C5Y6 Dublin
  Tel +353-1-772-8000
    Address record changed: 2020-12-02
Basic data Employees n. a.
  Currency USD
  Annual sales 240,717,000 (revenue, total, consolidated (07/08) 2008-03-31)
  Profit 166,979,000 (2008-03-31)
  Cash 460,361,000 (2008-03-31)
    * Document for �About Section�: Rodin Therapeutics Inc.. (11/18/19). "Press Release: Alkermes to Acquire Rodin Therapeutics". Dublin & Boston, MA.
Record changed: 2019-11-30


Picture EBD Group Global Partnering Four Events One Price 650x80

More documents for Alkermes (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture [iito] Back into Ad 650x80px

» top